| Literature DB >> 29475910 |
Tsung-Hsien Yen1, Chia-Ling Hsieh2, Tsu-Te Liu3, Chih-Sheng Huang4,5, Yen-Chung Chen6, Yao-Chen Chuang7, Song-Shei Lin8, Fei-Ting Hsu9,10,11,12.
Abstract
The goal of the present study was to investigate anticancer effect of amentoflavone on glioblastoma cells in vitro. Our results demonstrated that amentoflavone not only significantly reduced cell viability, nuclear factor-ĸappa B (NF-ĸB) activation, and protein expression of cellular Fas-associated protein with death domain-like interleukin 1 beta-converting enzyme inhibitory protein (C-FLIP) and myeloid cell leukemia 1 (MCL1), but significantly triggered cell accumulation at the sub-G1 phase, loss of mitochondrial membrane potential, and expression of active caspase-3 and -8. In order to verify the effect of NF-ĸB inhibitor on expression of anti-apoptotic proteins, we performed western blotting. We found that the of NF-ĸB inhibitor or amentoflavone markedly diminished protein levels of MCL1 and C-FLIP. Taken all together, our findings show that amentoflavone induces intrinsic and extrinsic apoptosis and inhibits NF-ĸB-modulated anti-apoptotic signaling in U-87 MG cells in vitro. CopyrightEntities:
Keywords: Glioblastoma; NF-ĸB; amentoflavone; apoptosis
Mesh:
Substances:
Year: 2018 PMID: 29475910 PMCID: PMC5905195 DOI: 10.21873/invivo.11235
Source DB: PubMed Journal: In Vivo ISSN: 0258-851X Impact factor: 2.155